XTL Biopharmaceuticals Ltd.

_________ false


�� "�	2 381
X T L BIOPHARMACEUTICALS LTD
Corporation no: 520039470	4313
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	10/07/2017
	www.isa.gov.il			www.tase.co.il				Reference:	2017-02-072084	Time of broadcast: 14:03 14:01:38

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.


Attached hereto is a report on	On July 9, 2017, the three-year term of Gil Oren, an external director of Can-Fite Biopharma Ltd. (the �Company�) and member of the audit committee and compensation committee of the Company, automatically expired. Mr. Oren may not be re-elected to serve as an external director for an additional term as he was elected for the maximum number of terms permitted under the Israeli Companies Law. As previously reported, on July 25, 2017, the Company plans to hold its 2017 Annual General Meeting of Shareholders, at which meeting, among other things, Yaacov Goldman, is standing for election to replace Mr. Oren as an external director and as a member of the Company�s audit committee and compensation committee.

Attached hereto is a report on

On July 9, 2017, the three-year term of Gil Oren, an external director of Can-Fite Biopharma Ltd. (the �Company�) and member of the audit committee and compensation committee of the Company, automatically expired. Mr. Oren may not be re-elected to serve as an external director for an additional term as he was elected for the maximum number of terms permitted under the Israeli Companies Law. As previously reported, on July 25, 2017, the Company plans to hold its 2017 Annual General Meeting of Shareholders, at which meeting, among other things, Yaacov Goldman, is standing for election to replace Mr. Oren as an external director and as a member of the Company�s audit committee and compensation committee.

f6k071017_canfitebiopharmaEDGAR1_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 28/06/2017
Address: HaCharoshet st 5 , Ra'anana 43656 Israel , Tel: 09-9557080 , Fax: 09-9519708
E-mail address: [email protected] Company site: www.xtlbio.com

Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD

Name of the Signatory: Kntor Ronen Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company:
Address: abba hillel 12 , ramat gan 5250606 Telephone: 03-6133371 Facsimile: 03-6133372 E-mail: [email protected] 1

AI Terminal

7116_rns_2017-07-10_264e107c-d5ff-49d9-8875-f64c682fde6c.htm

More from XTL Biopharmaceuticals Ltd.

Talk to a Data Expert